神经轴麻醉和前列腺切除术后癌症复发:在盒子之外思考
Maria P Ntalouka1, Panagiotis J Vlachostergios2,3,4, Metaxia Bareka1
1Department of Anesthesiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa University Hospital, 41110 Larissa, Greece.
Pharmacy (Basel, Switzerland)
|September 22, 2025
概括
与全身麻醉相比,神经轴麻醉可以改善前列腺癌前列腺切除术后的生存率,特别是在患有并发症的患者中. 需要进一步的研究来澄清其对癌症复发和长期结果的影响.
科学领域:
- 瘤学和麻醉学 麻醉学
- 手术瘤学手术瘤学
- 在外科手术期间的医学.
背景情况:
- 激进前列腺切除术 (RP) 是局部前列腺癌 (PC) 的标准治疗方法.
- 包括麻醉类型在内的外科手术因素可能通过促进瘤传播状态来影响PC预后.
- 机制包括同情激活,增加阿片类药物使用和炎症.
研究的目的:
- 审查术后期对PC预后和患者结果的影响.
- 调查神经轴麻醉与PC的RP后的结果之间的关联.
主要方法:
- 进行了非系统的文献综述.
- 关键词包括:"癌症复发"或"癌症预后"或"转移"和"神经动脉麻醉"和"前列腺癌".
- 符合条件的研究被总结为叙述性综述格式.
主要成果:
- 与全身麻醉相比,神经轴麻醉与手术后的死亡率降低有关,特别是在有限的ERAS协议时代.
- 麻醉技术和癌症无复发生存率 (放射性或生物化学) 之间没有发现显著的关联.
- 区域麻醉可能有利于严重并发症患者的短期生存,可能减少肺部并发症和血栓形成.
结论:
- 麻醉技术对PC患者结局的影响需要进一步调查,因为目前的证据是初步的,并且在很大程度上是追溯的.
- 初步证据表明,神经轴麻醉对患者的治疗结果可能有积极影响.
- 外科医生和瘤麻醉师之间的合作在脆弱的外科手术前期至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
589
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
589
Local Anesthetics: Clinical Application as Spinal Anesthesia
1.3K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.3K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
605
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
605
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
676
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
676
General Anesthesia: Overview
592
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
592


